meridian bioscience

Antares Pharma Ranks the Highest in Terms of Revenue Per Employee in the Health Care Supplies Industry (AIS, VIVO, CERS)

Published on Tue, 05/08/2012 - 10:11
By Adrienne Chilton in Fast Lane, AIS, CERS, VIVO, amex:ais, antares pharma, cerus, highest revenue per employee, meridian bioscience, nasdaq:cers, nasdaq:vivo
AIS

By Adrienne Chilton
achilton@fnno.com

Meridian Bioscience Makes a Move: Down 2.3%

Published on Wed, 05/02/2012 - 10:14
By Adrienne Chilton in Market movers, VIVO, market movers, meridian bioscience, nasdaq:vivo
VIVO

By Adrienne Chilton
achilton@fnno.com

Meridian Bioscience Shares Sinking Lower, Down 2.2%

Published on Wed, 05/02/2012 - 09:06
By Mallory Stone in Market movers, VIVO, market movers, meridian bioscience, nasdaq:vivo
VIVO

By Mallory Stone
mstone@fnno.com

Best Relative Performance in the Health Care Supplies Industry Detected in Shares of Endologix (ELGX, VIVO, ALR, ALGN, XRAY)

ELGX

By Robert Cotter
rcotter@fnno.com

Shares of Meridian Bioscience Are Moving Higher on 1.6x Above-Average Volume (VIVO)

Published on Thu, 04/26/2012 - 13:08
By Adrienne Chilton in Unusual volume, VIVO, meridian bioscience, nasdaq:vivo, unusual volume
VIVO

By Adrienne Chilton
achilton@fnno.com

Meridian Bioscience Trading Higher on 1.6x Above-Average Volume (VIVO)

Published on Thu, 04/26/2012 - 13:06
By Adrienne Chilton in Unusual volume, VIVO, meridian bioscience, nasdaq:vivo, unusual volume
VIVO

By Adrienne Chilton
achilton@fnno.com

Meridian Bioscience Shares Climbing Higher, Up 5.4%

Published on Thu, 04/26/2012 - 11:55
By Peter Chu in Market movers, VIVO, market movers, meridian bioscience, nasdaq:vivo
VIVO

By Peter Chu
pchu@fnno.com

Meridian Bioscience Makes a Move: Up 2.2%

Published on Wed, 04/25/2012 - 12:18
By Robert Cotter in Market movers, VIVO, market movers, meridian bioscience, nasdaq:vivo
VIVO

By Robert Cotter
rcotter@fnno.com

Meridian Bioscience is Among the Companies in the Health Care Supplies Industry With the Highest Dividend Yield (VIVO, UTMD, SPAN)

VIVO

By Peter Chu
pchu@fnno.com

Shares of Meridian Bioscience Under Pressure, Down 3.2%

Published on Mon, 04/23/2012 - 10:47
By Mallory Stone in Market movers, VIVO, market movers, meridian bioscience, nasdaq:vivo
VIVO

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Analyst Rating In Review: Ducommun Sold ...

One week ago Ducommun (NYSE:DCO) was downgraded from Buy to Hold at BB&T Capital. The ...

Analyst Rating Flashback: Analog Devices...

Analog Devices was downgraded from Buy to Neutral by UBS one week ago. The shares clos ...

Janney Montgomery Made the Right Call, C...

Chiquita Brands International was downgraded from Buy to Neutral by Janney Montgomery o ...

CF Industries Gives Way to the Analysts:...

One week ago CF Industries (NYSE:CF) was downgraded from Hold to Sell at Dahlman Rose. ...

Parkway Properties Down 2.9% Since BMO C...

A week ago, BMO Capital upgraded Parkway Properties from Underperform to Market Perform ...

Analyst Rating In Review: Marvell Techno...

One week ago Marvell Technology (NASDAQ:MRVL) was downgraded from Buy to Neutral at UBS ...

Analyst Rating In Review: MercadoLibre S...

A week ago, Raymond James downgraded MercadoLibre from Outperform to Market Perform. T ...

Analyst Rating Flashback: Humana Down 3....

A week ago, Goldman Sachs downgraded Humana from Buy to Neutral. Humana stocks closed ...

Most Popular Video News